Wearable Device to Treat Opioid Withdrawal Symptoms Approved By FDA

The device can curb anxiety, irritability, depression and opiate cravings without narcotics, according to its manufacturer. The U.S. Food and Drug Administration (FDA) has cleared a wearable device (simply named “Drug Relief”) that reduces common opioid withdrawal symptoms, according to Markets Insider. DyAnsys, the device’s manufacturer, claims the device will curb anxiety, irritability, depression and… Continue reading Wearable Device to Treat Opioid Withdrawal Symptoms Approved By FDA

Potential Treatment To Prevent Relapse Shows Promise

Researchers only tested the treatment mechanism out on morphine though they are interested in seeing if it works on other drugs. The journal Addiction Biology published research from scientists at the University of Bath which offers a new mechanism for preventing drug-addiction relapses. According to Medical Xpress, the Bath scientists collaborated with colleagues from RenaSci and… Continue reading Potential Treatment To Prevent Relapse Shows Promise

Over 200 Common Medications May Cause Depression, Study Warns

The researchers described the study as the first to successfully prove that when common drugs are used at the same time, the risk for adverse side effects rises. More than one-third of American adults take medications that might trigger depression and thoughts of suicide, ABC News reported. According to a new study, more than 200… Continue reading Over 200 Common Medications May Cause Depression, Study Warns

Massachusetts Could Become Marijuana Research Hub

“My vision is Massachusetts could be the number one leading cannabis research state in the world,” said one public health official. After Massachusetts voterslegalized marijuana for adult use in 2016, sales of the drug are slated to start this July, leaving many Bay State businesses scrambling to position the state as a leader for marijuana research.… Continue reading Massachusetts Could Become Marijuana Research Hub

New Generation Of Antidepressants On FDA Fast Track

The medications, which are still in development, may be able to help those who have not found success with currently available antidepressants. Pharmaceutical companies are honing in on the potential of ketamine and more to provide fast-acting antidepressant relief, Healthline reports. Two examples are Janssen Pharmaceuticals’ esketamine nasal spray and Allergan’s rapastinel (a different, but… Continue reading New Generation Of Antidepressants On FDA Fast Track

House Passes 25 Bills To Aid Fight Against Opioid Crisis

The bills cover a variety of issues ranging from improving sober living homes to disposal of unused medication. In an effort to lend legislative support to the fight against the national opioid epidemic, the House of Representatives passed 25 bills that would provide crucial support to both government and public organizations to combat the crisis on… Continue reading House Passes 25 Bills To Aid Fight Against Opioid Crisis

I'm Sorry Daddy, I Won't Be at Your Funeral

I used to think my relationship with my father was unique, different: complicated on its best day and toxic, disruptive, and unbearable on its worst. I know now it’s not unique. I have always known—well maybe not always, but for a very long time—that I would most likely not be attending my father’s funeral. I… Continue reading I'm Sorry Daddy, I Won't Be at Your Funeral

What's Fueling The Rise Of Meth?

Ohio, Nevada, Utah and parts of Montana have seen a recent rise in methamphetamine use.  In rural Ohio, an increasing number of opioid users are turning to methamphetamine to get high, driven in part by a medication that is meant to help them stay sober.  “Right now that’s our biggest challenge—is methamphetamines,” Amanda Lee, a counselor at Health Recovery… Continue reading What's Fueling The Rise Of Meth?

Anheuser Busch Pulls Out Of Federal Drinking Moderation Study

The alcohol company was set to contribute $15.4 million over a 10-year period for the study. One major backer of a $100 million federal study related to alcohol consumption has pulled out due to surrounding controversy.  According to the New York Times, Anheuser-Busch InBev, a Belgian-Brazilian brewing company, was to be one of five alcohol… Continue reading Anheuser Busch Pulls Out Of Federal Drinking Moderation Study

SAMHSA’s Opioid Overdose Prevention Toolkit Gets An Update

The refreshed online resource offers a variety of strategies, information and advice on how to prevent opioid overdoses.  The Substance Abuse and Mental Health Services Administration (SAMHSA) has updated its Opioid Overdose Prevention Toolkit, which contains resources about opioid overdose prevention. The toolkit is divided into various sections, depending on the target audience.  The beginning… Continue reading SAMHSA’s Opioid Overdose Prevention Toolkit Gets An Update

Exit mobile version